These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 16304570)
1. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Creutzig U; Zimmermann M; Ritter J; Reinhardt D; Hermann J; Henze G; Jürgens H; Kabisch H; Reiter A; Riehm H; Gadner H; Schellong G Leukemia; 2005 Dec; 19(12):2030-42. PubMed ID: 16304570 [TBL] [Abstract][Full Text] [Related]
2. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Gibson BE; Wheatley K; Hann IM; Stevens RF; Webb D; Hills RK; De Graaf SS; Harrison CJ Leukemia; 2005 Dec; 19(12):2130-8. PubMed ID: 16304572 [TBL] [Abstract][Full Text] [Related]
3. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120 [TBL] [Abstract][Full Text] [Related]
4. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380 [TBL] [Abstract][Full Text] [Related]
5. [Improved treatment results in children with AML: Results of study AML-BFM 93]. Creutzig U; Berthold F; Boos J; Fleischhack G; Gadner H; Gnekow A; Graubner U; Henze G; Hermann J; Imbach P; Jürgens H; Kabisch H; Körholz D; Niemeyer CM; Reinhardt D; Reiter A; Ritter J; Spaar HJ; Zimmermann M; Klin Padiatr; 2001; 213(4):175-85. PubMed ID: 11528551 [TBL] [Abstract][Full Text] [Related]
6. Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials. Kardos G; Zwaan CM; Kaspers GJ; de-Graaf SS; de Bont ES; Postma A; Bökkerink JP; Weening RS; van der Does-van den Berg A; van Wering ER; Korbijn C; Hählen K Leukemia; 2005 Dec; 19(12):2063-71. PubMed ID: 16107896 [TBL] [Abstract][Full Text] [Related]
7. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials. Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952 [TBL] [Abstract][Full Text] [Related]
8. [Effect of cranial irradiation on rate of recurrence in children with acute myeloid leukemia. Initial results of the AML-BFM-87 study. The AML-BFM Study Group]. Creutzig U; Ritter J; Heyen P; Berthold F; Henze G; Kabisch H; Lampert F; Niethammer D; Riehm H; Schellong G Klin Padiatr; 1992; 204(4):236-45. PubMed ID: 1518259 [TBL] [Abstract][Full Text] [Related]
9. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93. Creutzig U; Ritter J; Zimmermann M; Reinhardt D; Hermann J; Berthold F; Henze G; Jürgens H; Kabisch H; Havers W; Reiter A; Kluba U; Niggli F; Gadner H J Clin Oncol; 2001 May; 19(10):2705-13. PubMed ID: 11352963 [TBL] [Abstract][Full Text] [Related]
10. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Ravindranath Y; Chang M; Steuber CP; Becton D; Dahl G; Civin C; Camitta B; Carroll A; Raimondi SC; Weinstein HJ; Leukemia; 2005 Dec; 19(12):2101-16. PubMed ID: 16136167 [TBL] [Abstract][Full Text] [Related]
11. [Analysis of causes of death during intensive chemotherapy according to treatment protocol AML-BFM 93]. Creutzig U; Zimmermann M; Reinhardt D; Lehrnbecher T Klin Padiatr; 2003; 215(3):151-8. PubMed ID: 12778355 [TBL] [Abstract][Full Text] [Related]
12. Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report. Entz-Werle N; Suciu S; van der Werff ten Bosch J; Vilmer E; Bertrand Y; Benoit Y; Margueritte G; Plouvier E; Boutard P; Vandecruys E; Ferster A; Lutz P; Uyttebroeck A; Hoyoux C; Thyss A; Rialland X; Norton L; Pages MP; Philippe N; Otten J; Behar C; Leukemia; 2005 Dec; 19(12):2072-81. PubMed ID: 16136166 [TBL] [Abstract][Full Text] [Related]
13. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Möricke A; Zimmermann M; Reiter A; Henze G; Schrauder A; Gadner H; Ludwig WD; Ritter J; Harbott J; Mann G; Klingebiel T; Zintl F; Niemeyer C; Kremens B; Niggli F; Niethammer D; Welte K; Stanulla M; Odenwald E; Riehm H; Schrappe M Leukemia; 2010 Feb; 24(2):265-84. PubMed ID: 20010625 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of chemotherapy alone with allogeneic bone marrow transplantation in first full remission in children with acute myeloid leukemia in the AML-BFM-83 and AML-BFM-87 studies--matched pair analysis]. Creutzig U; Bender-Götze C; Klingebiel T; Ebell W; Friedrich W; Stollmann-Gibbels B; Schmidt H; Suttorp M; Gratwohl A; Heyen P Klin Padiatr; 1992; 204(4):246-52. PubMed ID: 1518260 [TBL] [Abstract][Full Text] [Related]
15. Treatment results of three consecutive German childhood AML trials: BFM-78, -83, and -87. AML-BFM-Group. Ritter J; Creutzig U; Schellong G Leukemia; 1992; 6 Suppl 2():59-62. PubMed ID: 1578943 [TBL] [Abstract][Full Text] [Related]
16. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children]. Reinhardt D; Hempel G; Fleischhack G; Schulz A; Boos J; Creutzig U Klin Padiatr; 2002; 214(4):188-94. PubMed ID: 12165900 [TBL] [Abstract][Full Text] [Related]
17. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95. Schrauder A; Reiter A; Gadner H; Niethammer D; Klingebiel T; Kremens B; Peters C; Ebell W; Zimmermann M; Niggli F; Ludwig WD; Riehm H; Welte K; Schrappe M J Clin Oncol; 2006 Dec; 24(36):5742-9. PubMed ID: 17179108 [TBL] [Abstract][Full Text] [Related]
18. Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials. Lie SO; Abrahamsson J; Clausen N; Forestier E; Hasle H; Hovi L; Jonmundsson G; Mellander L; Siimes MA; Yssing M; Zeller B; Gustafsson G; ; Leukemia; 2005 Dec; 19(12):2090-100. PubMed ID: 16304571 [TBL] [Abstract][Full Text] [Related]
19. Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group. Perel Y; Auvrignon A; Leblanc T; Michel G; Reguerre Y; Vannier JP; Dalle JH; Gandemer V; Schmitt C; Méchinaud F; Lejars O; Piguet C; Couillaud G; Pautard B; Landman-Parker J; Thuret I; Aladjidi N; Baruchel A; Leverger G; Leukemia; 2005 Dec; 19(12):2082-9. PubMed ID: 16121218 [TBL] [Abstract][Full Text] [Related]
20. [Improved results in the treatment of acute myeloid leukemia - Results of study AML-BFM-93 in East Germany with comparisons to the preceding studies AML-I-82 and AML-II-87]. Steinbach D; Dörffel W; Eggers G; Holfeld E; Kluba U; Krause I; Lauterbach I; Reiss T; Rieske K; Scharfe V; Schumacher R; Weigel H; Weinmann G; Zintl F; Hermann J Klin Padiatr; 2001; 213(4):162-8. PubMed ID: 11528549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]